Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Natural phytocompounds targeting tau protein: therapeutic potential in Alzheimer's disease.

Created on 21 Nov 2026

Authors

Nada M Kamel, Alaa H Amin, Mostafa A Rabie, Shymaa Hatem, Ahmed M El-Dessouki, Asmaa A Mandour, Riham A El-Shiekh, Shaza H Aly

Published in

The Journal of pharmacy and pharmacology. Volume 78. Issue 11. Nov 04, 2026.

Abstract

Alzheimer's disease (AD) is a major and growing neurodegenerative disorder characterized by progressive cognitive and functional decline. Accumulating evidence indicates that pathological tau is closely associated with disease progression and cognitive impairment, supporting tau-directed therapeutic strategies.
This review provides a tau-centered mechanistic and translational synthesis of structurally defined phytocompounds, integrating evidence on kinase/phosphatase regulation, tau post-translational modifications, aggregation and propagation, autophagy-mediated clearance, neuroinflammation, oxidative stress, mitochondrial dysfunction, gut-brain signaling, and epigenetic regulation. Unlike reviews that mainly catalogue natural products with anti-Alzheimer activity, we distinguish direct tau-related effects from broader neuroprotective actions and critically consider evidence from biochemical, computational, cellular, animal, and available clinical studies. Major translational barriers, including poor solubility, metabolic instability, limited bioavailability, and insufficient blood-brain barrier penetration, are also discussed, together with nanocarrier-based strategies developed to improve brain delivery. Natural phytocompounds, including flavonoids, polyphenols, stilbenes, terpenoids, and alkaloids, have shown potential to modulate tau-related pathology through multiple mechanisms.
By linking molecular mechanisms with experimental evidence and delivery considerations, this review highlights both the therapeutic promise and the remaining challenges of phytocompounds as modulators of tau pathology in AD.

PMID:
43062985
Bibliographic data and abstract were imported from PubMed on 21 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement